mesalamine has been researched along with Sarcoma, Synovial in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Sarcoma, Synovial: A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Iñiguez, A | 1 |
| Pérez-Gutiérrez, MT | 1 |
| Lambraño-Castillo, D | 1 |
| Sierra-Madero, JG | 1 |
| Omoteyama, K | 1 |
| Sato, T | 1 |
| Arito, M | 1 |
| Sato, M | 1 |
| Suematsu, N | 1 |
| Kurokawa, MS | 1 |
| Kato, T | 1 |
2 other studies available for mesalamine and Sarcoma, Synovial
| Article | Year |
|---|---|
Necrotic lesion in an immunosuppressed patient.
Topics: Aged; Colitis, Ulcerative; Ecthyma; Fatal Outcome; Gangrene; Humans; Immunocompromised Host; Immunos | 2018 |
Effects of salazosulfapyridine on the profile of cell surface proteins, revealed by biotinylation of cell surface proteins and 2-dimentional electrophoresis.
Topics: Biotinylation; Cell Line, Tumor; Humans; Membrane Proteins; Mesalamine; Sarcoma, Synovial; Sulfapyri | 2019 |